Assignee profile:

ABION INC.

City:

Seoul

Country:

South Korea

Published Applications:

16

Last publication date:

2023-08-03

Patent Grants:

16

Last grant date:

2025-08-05

Top Inventors for applications by ABION INC.

These are the the leading inventors for applications assigned to ABION INC.:

Recent patent applications by ABION INC.

ABION INC. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-03 ✅ Patent 12,377,132 granted on 2025-08-05
US20230241176A1
Human necessities

COMPOSITION FOR TREATING OR SENSITIZING INTERFERON BETA RESISTANT CANCER DISEASE COMPRISING CFLIP SIRNA

#2 | 2022-07-28 ✅ Patent 11,987,582 granted on 2024-05-21
US20220235054A1
Chemistry; metallurgy

Maleate salts of triazolopyrazine derivatives, compositions, methods of use, and processes of manufacturing the same

#3 | 2022-07-14 ✅ Patent 12,173,074 granted on 2024-12-24
US20220220207A1
Chemistry; metallurgy

Anti-c-Met agonist antibody and use thereof

#4 | 2021-09-30 ✅ Patent 11,464,832 granted on 2022-10-11
US20210299225A1
Human necessities

Composition for treating or sensitizing interferon beta resistant cancer disease comprising cFLIP siRNA

#5 | 2021-04-22 ✅ Patent 12,098,198 granted on 2024-09-24
US20210115134A1
Chemistry; metallurgy

Antibody binding specifically to ECL-2 of claudin 3, fragment thereof, and use thereof

#6 | 2020-04-02 ✅ Patent 11,111,536 granted on 2021-09-07
US20200102614A1
Chemistry; metallurgy

Method for determining cross contamination of mouse genes for human cells in a patient-derived xenograft cells

#7 | 2019-09-05 ✅ Patent 10,538,529 granted on 2020-01-21
US20190270747A1
Chemistry; metallurgy

Polymorphic forms of triazolopyrazine derivatives and method of preparing the same

#8 | 2019-08-15 ✅ Patent 11,286,296 granted on 2022-03-29
US20190248878A1
Chemistry; metallurgy

Anti-human ninjurin-1 (NINJ-1) antibodies and methods for detecting human NINJ-1

#9 | 2019-08-15 ✅ Patent 11,207,411 granted on 2021-12-28
US20190247506A1
Human necessities

Stabilized preparation of interferon beta variant

#10 | 2019-01-10 ✅ Patent 11,107,552 granted on 2021-08-31
US20190012429A1
Physics

Data processing, analysis method of gene expression data to identify endogenous reference genes

#11 | 2018-04-26 ✅ Patent 10,576,158 granted on 2020-03-03
US20180110860A1
Human necessities

Immune conjugate having dendron conjugated to antibody and use thereof

#12 | 2018-03-08 ✅ Patent 10,304,561 granted on 2019-05-28
US20180068057A1
Physics

Data processing, analysis method of gene expression data to identify endogenous reference genes

#13 | 2017-11-09 ✅ Patent 10,472,678 granted on 2019-11-12
US20170321275A1
Chemistry; metallurgy

Reagent for detecting cross contamination of PDX-model related with human and mouse, the kit comprising the same, and the method for the cross contamination detection

#14 | 2017-07-27 ✅ Patent 11,759,500 granted on 2023-09-19
US20170209588A1
Human necessities

PEGylated interferon-beta variant

#15 | 2015-10-22 ✅ Patent 9,719,093 granted on 2017-08-01
US20150299711A1
Chemistry; metallurgy

Composition for treating cancer associated with HPV infection

#16 | 2014-09-18 ✅ Patent 9,751,941 granted on 2017-09-05
US20140274755A1
Chemistry; metallurgy

Antigen derived from extracellular domain of multi-transmembrane protein and uses thereof

Also check out ABION INC.'s (Seoul, South Korea) applicant profile with 23 patent applications submitted.

AssigneeID:

152074 ⎘